retatrutide cancer Eli Lilly's drug, not FDA approved, accessed through experimental treatment program Incretin triple agonist retatrutide (LY3437943)

Heres what the weight-loss conversation keeps missing.

Starting today with Hims & Hers, eligible customers can access the only FDA-approved GLP-1 weight loss pill alongside a broad assortment of treatment options.

Do not reuse

Medicaid policies on GLP-1 weight loss medications differ significantly across states, with many requiring prior authorization or limiting coverage to diabetes treatment

From $1.73 Per Day

Method We systematically searched PubMed and Embase from inception to 1 May 2025 for cohort studies comparing the effect of combination therapy with SGLT2 inhibitor or GLP-1 RA monotherapy on (cardiovascular) mortality and cardiovascular or kidney endpoints in individuals with type 2 diabetes